Clinical Trial Update: Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 randomized trial evaluating immunodynamics-guided optimization of individualized immunochemotherapy for advanced driver-negative non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Advanced Non-Small Cell Lung Cancer (NSCLC) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING